JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
Technology Transfer
Spend 30-40 minutes on this section
Sign in to Google
to save your progress.
Learn more
What group are you in?
Choose
1- Eradicators
2-Flu Fighters
3-The Plague
4-Blue Fever
5-Team Viral
6-The WHO
7-The Influenza Invasion
8-The Vaccinators
9-Flu Devils
10-The Hot Zone
11-MDR-BD
What is your stakeholder perspective?
Choose
USA -1
USA-2
WHO-1
WHO-2
Industry-North
Industry-South
China-1
China-2
China-3
Academic/research institutions-1
Academic/research institutions-2
Is your group in Tech Transfer B ?
yes
no
Clear selection
1.Imagine that a research institution/corporation in an industrialized country holds the intellectual property key to developing a vaccine that could arrest the spread of the pandemic. In times of pandemic, should such an organization be required to license or transfer the technology in a way that would ensure affordable access to the final treatment in developing countries?
Not at all
1
2
3
4
5
Yes, absolutely
Clear selection
2. Technology transfer can take various forms. What does your stakeholder group see as an institutions’ acceptable commitments for technology transfer to meet needs for manufacturing a vaccine during a pandemic? (Consider all that might be non-negotiable and that must be part of the package for your stakeholder group).
Acceptable
Non-Acceptable
Make donated vaccines available
Ensure lower prices for vaccines for those unable to afford product
Provide support to manufacture vaccines domestically
Provide humanitarian access licensing to R&D inputs to produce vaccines
Provide financial returns/royalties from vaccine sales
Acceptable
Non-Acceptable
Make donated vaccines available
Ensure lower prices for vaccines for those unable to afford product
Provide support to manufacture vaccines domestically
Provide humanitarian access licensing to R&D inputs to produce vaccines
Provide financial returns/royalties from vaccine sales
Clear selection
3. Who should receive the benefits?
Rate the importance of the listed factor in determining whether or not a country should receive benefits (1= least important, 5 = most important)
1
2
3
4
5
Classification as a low or middle income country
Prevalence of disease
Participation in GISN network (history of sharing samples)
Other
1
2
3
4
5
Classification as a low or middle income country
Prevalence of disease
Participation in GISN network (history of sharing samples)
Other
Clear selection
3a. If you listed "other" above, please list the factor below
Your answer
4. Who should bear the cost of providing benefits?
Rate the responsibility of each institution for providing benefits (1 = no responsibility, 5 = most responsible)
1
2
3
4
5
Industry
Developing country governments
Industrialized country governments
Other
1
2
3
4
5
Industry
Developing country governments
Industrialized country governments
Other
Clear selection
4a. If you listed "other" above, please list the factor:
Your answer
5. How would you structure the technology transfer arrangement?
Would you include the following elements in seeking to structure a tech transfer arrangement?
Yes
No
Seek voluntary commitments
Support through a publicly funded program
Make it a requirement for public purchase of vaccine
Threaten compulsory licensing for failure to comply
Other
Yes
No
Seek voluntary commitments
Support through a publicly funded program
Make it a requirement for public purchase of vaccine
Threaten compulsory licensing for failure to comply
Other
Clear selection
5a. If you answered "other" above, please list the element:
Your answer
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google.
Report Abuse
-
Terms of Service
-
Privacy Policy
Forms
